Adam S, Simon N, Steffen U, Harre N, Andes F, Mueller D, Culemann S, Andreev D, Hahn M, Scholtysek C, Schett G, Krönke G, Frey S, Hueber A (2019)
Publication Type: Conference contribution
Publication year: 2019
Publisher: BMJ PUBLISHING GROUP
City/Town: LONDON
Pages Range: 110-110
Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES
DOI: 10.1136/annrheumdis-2019-eular.4104
APA:
Adam, S., Simon, N., Steffen, U., Harre, N., Andes, F., Mueller, D.,... Hueber, A. (2019). JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO. In ANNALS OF THE RHEUMATIC DISEASES (pp. 110-110). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
MLA:
Adam, Susanne, et al. "JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO." Proceedings of the Annual European Congress of Rheumatology (EULAR), Madrid LONDON: BMJ PUBLISHING GROUP, 2019. 110-110.
BibTeX: Download